Abstract
A meta-analysis published in 2018 concluded that mid-term and long-term mortality was higher in patients treated with paclitaxel eluting balloons and stents than in those treated with bare devices after the endovascular treatment of femoropopliteal lesions. There are no national data concerning the safety of these devices. We designed the DETECT (Drug EluTing dEvices FrenCh safeTy survey) study in order to compare the risk of mortality in patients treated with paclitaxel eluting balloons and/or stents or with bare devices.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
